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5 Abstract 
   
This paper investigates the process variables involved in layer-by-layer (LbL) fabrication of 
protein nanotubes.  Three main process variables were identified as having potential to 
significantly affect end results.  These included protein concentration, solution volume used per 
layer, and storage time.  The effects of each variable on protein activity were studied through 
controlled experiments and then rationalized in this report. 
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6 Executive Summary
 
Index Terms—Avidin, Glucose Oxidase, Layer-by-
Layer, and Nanotube. 
 
INTRODUCTION 
HIS document summarizes our research 
investigating the process variables involved in 
creating layer-by-layer (LbL) protein nanotubes.  
Nanotubes have great potential in medical 
applications.  They have shown ability to carry 
proteins into cell nuclei [1] and have potential for 
transporting genetic material across cell membranes 
as well [2]. 
    Nanotubes are extremely versatile and can be made 
from numerous materials.  Currently the most 
popular nanotubes are made from carbon.  Carbon 
nanotubes can be functionalized to increase 
biocompatibility, but still pose risks of cytotoxicity 
[2]. 
    Many proteins are already FDA approved.  This 
has sparked an interest in fabricating nanotubes 
entirely from protein.  Researchers have established 
two major methodologies for protein nanotube 
synthesis.  The first is self-assembly [3-6].  The 
downfall of this method being that the end result is 
limited to the chemistry and functionality of the 
biomolecule.  Alternatively, layer-by-layer 
techniques offer more control to the researcher [7-9].  
This method is also compatible with a greater number 
of proteins than self-assembly. 
 
METHODOLOGY 
Protein Preparation 
Layer-by-layer methodologies for protein nanotube 
fabrication are based on electrostatic charges holding 
positive and negative layers of proteins together.  We 
chose avidin (isoelectric point pH 10) and glucose 
oxidase (isoelectric point pH 4.2) as our proteins.  
Each was suspended in phosphate buffered saline 
(PBS) to maintain a neutral pH, providing avidin with 
a positive charge and glucose oxidase a negative 
charge. 
Layer Deposition 
Protein layers were obtained by vacuum filtering 
PBS, avidin, and glucose oxidase, respectively, 
through a 200 nm anodized aluminum oxide (AAO) 
template followed by a 50 nm polycarbonate 
membrane.  Filtering all three reagents through once 
was considered one nanotube layer.  In each test three 
layer nanotubes were used.  After all layers were 
deposited 1 mL PBS was filtered through to remove 
any loose proteins from the templates.  The 
nanotubes were left in the AAO templates for 
characterization. 
Variable Testing 
Protein concentration – To test the effect of 
protein concentration on nanotube formation, 
solutions of both proteins were made in 
concentrations of 0.1, 0.5, and 1 mg/mL.   A volume 
of 200 µL of solution was used each time a protein 
was filtered through the membranes.  
Characterization of the nanotubes created from each 
solution was then performed via glucose activity 
assay. 
Solution volume – Three different volumes (100, 
200, and 300 µL) of 1 mg/mL protein solution were 
tested in making the nanotubes.  These were 
characterized via glucose activity assay. 
Storage time – The effect of storage on protein 
functionality in nanotubes was investigated by 
checking the glucose activity rates initially, after one 
day, and after eleven days.   
RESULTS AND DISCUSSION 
The transmission electron micrograph (TEM) seen 
in Fig. 1 confirms the presence of the avidin-glucose 
oxidase nanotubes being created by LbL technique.  
 
 
Fig. 1 TEM image of avidin-glucose oxidase 
nanotube (scale bar represents 100 nm.) 
 
T 
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Protein concentration’s effect on nanotube 
formation remains inconclusive.  Difficulty with the 
glucose oxidase activity assay prevented proper 
characterization of the nanotubes created by different 
protein concentrations.  For unknown reasons the 
absorbance measured were notably higher than our 
expectation.   We are still seeking an explanation. 
However, the absorbance measured in  the following 
two experiments were within a reasonable range. 
The volumetric effect of solution showed an 
increase in protein activity from 100 µL to 200 µL.  
There was no notable change from 200 µL to 300 µL.   
Since increasing solution volume increases 
production time, we consider 200 µL the ideal 
solution volume. 
 
 
 
Fig. 2: Nanotube protein activity as a function of 
solution volume. 
 
Storage time had a notable effect on the bioactivity 
of the protein nanotubes.  Fig. 3 shows the 
absorbance measured using a glucose activity assay.  
Repeated absorbance measured by UV-vis 
spectroscopy on the same samples shows a clear 
decrease in enzymatic activity for the glucose oxidase 
as a function of storage time. 
 Fig. 3 Protein Nanotube Activity as a Function of 
Storage Time 
CONCLUSIONS AND RECOMMENDATIONS 
Protein nanotube fabrication is a complex process 
with many variables.  Further work should be done to 
investigate the effect of protein concentration on 
nanotube formation.  The negative effect of storage 
on protein nanotubes indicates that storage technique 
and time need to be a consideration in protein 
nanotube applications. 
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 7 Introduction 
 As the field of pharmaceuticals is growing rapidly, so is the technology for drug delivery.  
Nanocapsules and nanotubes possess a variety of traits that make them attractive drug carrier 
candidates.   
 For example, carbon nanotubes have already proven effective in transporting proteins to 
selected cells [1].  Their small size allows for easy cellular uptake, and the proteins they carry 
have shown in vitro functionality [1].  Nanotubes possess great potential as a delivery system for 
small drug molecules and genetic material as well, the potential advantage over other delivery 
methods being the ease of fabrication and diversity as a nanocarrier [1].  Such technology could 
help overcome many of the difficulties associated with nano-scale medicine. 
 Carbon nanotubes pose the problem of biocompatibility.  As a result there has been an 
increased interest in the use of bionanomaterials in the fabrication of nanotubes.  The term 
bionanomaterial refers to nanoscale materials that are considered to be compatible with the living 
system.  Proteins, peptides, liposomes, and polymers are examples of bionanomaterials that have 
been approved for use within the human body by the Federal Drug Administration (FDA) [5].  
By fabricating nanostructures from biomaterials the problem of biocompatibility delaying FDA 
approval is circumvented, adding to the attractiveness of biomaterials for fabricating 
nanostructures.  
 The main objective of this study is to demonstrate the layer by layer (LbL) fabrication of 
protein nanotubes with controlled diameter, wall thickness and length using anodized aluminum 
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oxide (AAO) membranes as a template.  By suspending proteins in solutions above or below 
their isoelectric point we could manipulate the protein’s charge.  By alternately filtering 
positively and negatively charged proteins through a template, layers are expected be held 
together by an electrostatic charge on the inner walls of the template pores.  This would form a 
structure that could be quickly and easily fabricated.  Two proteins (avidin and glucose oxidase) 
were chosen for their different isoelectric points.  With avidin having an isoelectric point of pH 
10 [11] it would be positively charged when suspended in a pH 7 buffer solution.  On the 
contrary, glucose oxidase having an isoelectric point of 4.2 [12] would be negatively charged in 
a pH 7 buffer solution.  It is expected that wall thickness would be a function of how many layers 
were deposited on the pore walls.  Length is usually limited to the thickness of the template [6]; 
however, certain reports have shown difficulty in controlling the length of protein nanotubes [5].  
Originally, we also proposed to investigate a controlled cleaving process to trim the nanotubes to 
a uniform length.    Unfortunately, time and budget constraints did not allow us to explore the 
controlled cleaving, in the project we focused on investigating the process variables for forming 
layer-by-layer protein nanotubes.  These variables included storage time and technique, volume 
of solution filtered through template, and concentration of proteins in solution. 
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8 Literature Review  
 Gene therapy has recently become a pharmaceutical hotspot with the mapping of the 
human genome.  One of the present problems is how to efficiently, safely, and cost effectively 
deliver the genetic material to the target cells.  Viral vectors have shown potential in delivery of 
genetic material to cells.  Unfortunately, they face problems of scalability and biocompatibility 
[13].  Another vector, plasmid DNA, has considerable difficulty penetrating the cell and reaching 
the target nucleus on its own [2].  Nanotubes, nanocapsules, and nanoparticles all have potential 
to efficiently deliver genetic material across a cell membrane and even into the nucleus.  In one 
study plasmid DNA expressing β-galactosidase was attached to functionalized carbon nanotubes 
(f-CNT).  Gene transfer experiments were then performed comparing the effectiveness of f-CNT 
delivered DNA versus the cell uptake of DNA without the f-CNT.  Gene expression was five to 
ten times higher when the DNA was delivered by f-CNT [2].    
 There is much debate upon which mechanism the cell employs to uptake nanotubes.    
Some studies suggest that endocytosis is the main mechanism for cellular uptake of nanotubes 
[1].  This theory is supported by findings of f-CNT-protein conjugates within endosomes [1].  
Phagocytosis has also been suggested by some studies [3] and insertion and diffusion by others 
[2].  Transmission electron microscopy (TEM) can be used to visualize CNT within cells.  TEM 
images have shown CNT perpendicular to the cell membrane, which would suggest the insertion 
and diffusion theory [2].  This theory proposes that the CNT perforate and diffuse through the 
lipid bilayer without seriously damaging the cell [2].  In spite of the uncertainty regarding the 
uptake mechanism there is evidence to show that f-CNT have a high propensity to cross cell 
membranes [14, 15].  This has been shown by attaching fluorescently labeled proteins to the 
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nanotubes and comparing the fluorescence of their target cells before and after the nanotubes are 
introduced [1].   
In protein nanotube technology, two major fabrication techniques have evolved; self-
assembly and template-assisted assembly.  Self-assembly techniques are somewhat limited 
because the end result is unique to the chemistry and functionality of the biomolecule [16, 17, 
18, 19].  Studies of chiral lipid tubules have shown the ability to somewhat manipulate nanotube 
morphology [16].  By altering molecular structure, lipid concentration, and solution conditions 
the researchers were able to control the number of bilayers in the tubule walls.  However, they 
had no control over diameter.  Forming the tubules in water and mixtures of alcohol provided 
unique morphologies were formed [16].  It is possible that similar techniques could be used to 
control the morphologies of protein nanotubes as well. 
Another group engineered protein nanotubes from type IV pili (fiber-like protein 
polymers produced by many bacteria) from Pseudosomonas aeruginosa [17].  The nanotubes 
created from pili were found to bind to single stranded DNA with moderate affinity, adding to 
their potential as a vector for gene delivery.  Thus it is important to note that proteins are 
naturally involved in forming nanostructures with unique functions, and that natural phenomenon 
are an important place to look for nanotech inspiration.   
  Alternatively, the template-assisted method of nanotube fabrication is highly versatile 
and controllable.  The methodology is relatively simple and typically relies on either electrostatic 
charges to hold the protein layers together (layer-by-layer method) [6, 7] or the chemical cross-
linking of proteins (alternate immersion method) [5, 8, 9].   
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Many of the current methods for template assisted fabrication of protein nanotubes rely 
on chemical cross-linking to strengthen the weak bonds of proteins [5, 6, 8, 9].  Specifically, 
alternate immersion techniques involve preparing the template with a cross-linking agent such as 
glutaraldehyde before the template is immersed in a protein solution.  To lessen the non-specific 
binding of proteins to the face of the template (instead of the pore walls), the faces are often 
sputter coated with gold (Au).  Sputter coating with Au prevents the glutaraldehyde from 
attaching to the template face and thus lessens the chances of proteins adhering where they are 
not wanted [8].   
In alternate immersion techniques the number of layers is determined by the number of 
times the template is immersed in the cross-linking agent and then protein solution.  Other 
dimensional qualities of the nanotubes are largely dependent on the pore structure of the 
template, with the outside diameter always being defined by template pore size.  It stands to 
reason that template thickness would define overall nanotube length; however, at least one report 
has found otherwise [5].  Some advantages of this approach would be the control over 
dimensional qualities afforded to the user, while offering a wide variety of proteins to choose 
from.  This technique also creates very strong bonds due to the protein immobilizing unit 
glutaraldehyde.  Disadvantages would be the amount of time wasted soaking the template in 
different solutions, and lack of automation capability.  Also an unnecessary amount of protein 
may be used in creating enough solution to fully submerge the template each time a layer is 
created.   
Layer-by-layer techniques involve alternately filtering proteins through templates using 
either pressure or vacuum filtration.  This approach can be used in conjunction with cross-linking 
to strengthen the bonds or simply using electrostatic charges.  One study fabricated layer-by-
15 
 
layer nanotubes by alternately filtering cytochrome-c and glutaraldehyde [6].  Glutaraldehyde is 
often used to immobilize proteins by forming covalent bonds.  The same study also made protein 
nanotubes formed by alternately adsorbing layers of cytochrome-c and poly-(sodium 
styrenesulfonate) (PSS) onto membrane templates [6].  The cytochrome-C and PSS protein 
nanotubes were held together with electrostatic charges.  Cytochrome-c has an isoelectric point 
of pH 10.4 and is thus positive at pH 7.0, while PSS is negatively charged at pH 7.0 [6].  This 
methodology most closely reflects the one used to create protein nanotubes from avidin and 
glucose oxidase in this paper.  However, the study involving cytochrome-c and PSS nanotubes 
sputter coated their membranes with gold before protein deposition to prevent protein from 
remaining on the surface of the template.  The most notable advantage of utilizing a layer-by-
layer approach would be the ease of fabrication.  This process is less time consuming than 
alternate immersion methods and affords the user more control than self-assembly.  Protein 
waste could be minimized by determining minimum solution volume and solution concentration 
for optimum protein adsorption.  The process also possesses great potential for automation as it 
largely involves repetitive pipetting of solutions.   
As nanotechnology develops and potential medical applications begin to become 
realities, regulatory agencies such as the FDA will face new challenges.  Current FDA 
regulations may not effectively cover the new challenges of nanotechnology.  This gives rise to 
the new field of nanotoxicology.  The small size of nanoparticles also poses potential risk to 
researchers and anyone involved in their fabrication.  Their size lends to easy crossing of 
epithelial and endothelial layers, into the lymph and circulatory systems.  Nanoparticles could 
then reach potentially sensitive target sites such as bone marrow, lymph nodes, spleen and heart 
[20].  Although, it can be argued that nanoparticles are a naturally occurring phenomenon that 
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we have been exposed to all of our life (especially with the increase in pollution) researchers will 
need to perform serious risk assessments regarding nanoparticle fabrication. 
Another new area of study that will arise from the interest in nanoparticles as a drug 
delivery system will be in regards to how the nanoparticles are delivered.  Now it is unclear if 
nanotubes would be delivered orally, intravenously, transdermally, via implantation, etc.  
Therefore, the pathway that different nanoparticles take throughout the body will need to be 
extensively studied.  Some studies with carbon nanotubes have shown the specific targeting of 
tumors with antibody-functionalized radio-labeling [21].  However, there is always the 
possibility of nanotubes ending up where they are not wanted. 
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9 Project Approach 
9.1 Initial Approach 
 The layer-by-layer approach had shown promising results when used with cytochrome C 
(cyto-c) and Glutaraldehyde (GA) or PSS [6].  We initially felt that by alternately filtering avidin 
(isoelectric point – pH 10) suspended in solutions of pH 5 and pH 12 through 200 nm pore AAO 
templates, the opposite charges would be enough to hold together structures the size and shape of 
template pores.  Attempted characterization of the tubes via UV-vis showed questionable results 
(discussed in the Results section).  This led us to try soaking the templates in GA overnight after 
depositing the proteins on the pore walls.  The GA would supposedly act as a crosslinking agent 
and strengthen the bonds.  This caused dissolving of the templates to be extremely difficult and 
left an undesirable precipitate in the solution.   
 We then hypothesized that the alternate filtration of solutions of acidic then basic pH may 
actually just be changing the pH and consequently the charge of the protein inside the pores 
every time a solution is filtered through.  As a result, no electrostatic bonding was taking place 
and any measurements on the spectrometer indicating a peak at 282 nm was likely the result of 
loose protein, not nanotubes.   
9.2 Project Approach 
 These results lead us to rethink the project approach.  The opposing pH values had quite 
likely ruined the chances of maintaining opposite charges on the proteins to induce electrostatic 
bonding.  Thus, if we approached the same problem with solutions of neutral pH we would not 
disrupt the charges of the protein.  By selecting one protein that had an isoelectric point above 
pH 7 and another with an isoelectric point below pH 7 we felt we could effectively maintain 
opposite charges while alternately filtering the two protein solutions through the template.  We 
18 
 
then proposed to suspend avidin (isoelectric point pH 10) and glucose oxidase (GOx) (isoelectric 
point pH 4.2) in phosphate buffer saline (PBS), (pH 7) and alternately filter them through the 
same 200 nm AAO templates.   
 Using two different proteins in layer-by-layer fabrication of nanotubes is a more widely 
documented approach, which has shown success [6].  Since controlling the process variables of 
protein nanotube fabrication was our goal, we decided to stay with the more promising 
methodology for the rest of our studies. 
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10 Design 
Upon deciding to use two proteins with opposite isoelectric points suspended in neutral 
solution it was necessary to design a simple yet effective technique for fabricating the nanotubes.  
There were many design choices that had to be made, and they will be detailed in the following 
sections. 
10.1 Protein Choice Justification 
 The proteins for use in this project were chosen based on a few factors.  First, they are 
both readily available at a relatively low cost.  They are commonly used in labs and are available 
in a number of forms.  For example, avidin can be purchased in a fluorescent form, which could 
prove useful in further investigations of the nanotubes in living systems.  Their isoelectric points 
on opposite sides of the pH scale also were essential to the design of this process.  By 
maintaining a neutral pH in both solutions the avidin would maintain a negative charge and the 
glucose oxidase would be positive.   
10.2 Template Choice Justification 
 Anodized aluminum oxide membranes were chosen as a template for their availability in 
a wide array of pore sizes, thicknesses, and pore densities.  They can be fabricated in the lab 
using a well established two-step anodization procedure, which produces more uniform pores 
than the commercially available templates.  However, time was a major constraint in this project, 
so commercially available AAO discs were used as received from Whatman Corporation.  They 
had average pore size of 200 nm and a thickness of approximately 60 μm.  For any further 
continuations of this project it is recommended that templates are fabricated to the most uniform 
specifications possible. 
10.3 Choosing the Proper Nanotube Liberation Solvent 
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 Once the nanotubes are formed on the inner pores of the membrane, we needed a method 
of liberating them without damaging their structure.  To determine the appropriate chemical to 
dissolve the templates a simple experiment was setup with three AAO templates suspended in 
different chemicals and the time until the entire inner portion of the template was dissolved was 
recorded.  Some of the chemicals had been used to liberate nanotubes from templates in previous 
published works.   Each AAO template was soaked in a petri dish of 10 mL of either Sodium 
Hydroxide (NaOH), Phosphoric Acid (H3PO4.), or Hydrochloric Acid (HCl) and total dissolve 
time was recorded.  A template was considered totally dissolved when the clear plastic ring 
around the AAO was all that was left of the template.  In certain cases there was precipitate left 
on the bottom of the petri dish and this was noted in the results for it is an undesirable byproduct 
for the next step of the process.  The solvent that most rapidly and completely dissolved the 
templates was the NaOH.  
10.4 Storing the AAO Templates with Nanotubes 
As a result of the difficulties with nanotube liberation, we decided to characterize the 
nanotubes within the AAO templates.  Originally we had tried storing the templates dry in small 
containers in the lab refrigerator.  Since proteins are a biological material we questioned the 
effect that dry storage for any extended period of time would have on the proteins.  This led to 
our later study of protein activity as a function of dry storage time.  For all other studies this 
variable was circumvented by performing activity assays within a few hours of initial nanotube 
fabrication.  
10.5 Choosing the Process Variables to Study 
Initially, the main variable we sought to correct was non-uniform nanotube length.  Given 
the constraints of the project we needed to rethink the variable and decided to focus on process 
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variables instead.  The variables we found to cause the most inconsistency in the process were 
chosen with regard to how they could affect the end product. 
 
Figure 1: Process variables 
10.5.1 Volumes Filtered 
In the beginning we assumed that 200 µL was a sufficient volume of each protein 
solution to filter through the template for each layer.  The benefit of using such a small volume 
was that each time a protein needed to be deposited it only took approximately three minutes to 
vacuum filter through.  Seeing as the inside of each pore has a limited surface area only a certain 
amount of protein can adhere to the walls of the channel.  If we were depositing too much 
protein we could possibly be wasting time and expensive protein.  If we were using too little 
protein we could possibly be leaving gaps in the cylindrical structure of the NTS thus leaving it 
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incomplete.  Beyond these problems there was also the chance that too much solution may create 
too much flow through the channels and prevent proteins from properly adhering. 
10.5.2 Protein Concentration 
For similar reasons to finding the correct volume of solution to use, we needed to make 
sure the concentration of that solution was right.  To begin with we had used 1 mg/mL solutions 
for both Avidin and GOx.  Both proteins are expensive and therefore had to be used sparingly.  
But if the solution was not concentrated enough the proteins might not have the proper exposure 
to the channel walls.  On the other hand if it was overly concentrated we would have risked 
blocking the channels while unnecessarily wasting protein. 
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11 Methodology 
11.1 Avidin Preparation 
 To employ our design of the layer-by-layer method of protein nanotube fabrication it was 
necessary to have a solution of avidin at a pH of 7.  At a pH below the isoelectric point (pH 10) 
the avidin will carry a net positive charge.  PBS was chosen as the buffer solution because it is 
widely accepted for use of maintaining constant pH without denaturing proteins.   
 A 1 mg/mL concentration was made for the initial stock solutions.  Initially 10 mL of 
PBS were mixed with 10mg of avidin. 
11.2 Glucose Oxidase Preparation 
 The GOx was prepared with the same basic technique as the avidin solution.  PBS was 
again used to maintain the pH without denaturing the protein, giving the GOx a negative charge.  
The 1 mg/mL concentration was again used to prepare 10 mL of solution using 10 mg of glucose 
oxidase. 
11.3 Peak Absorbance Determination 
 After creating each stock solution peak absorbance was measured using a UV-vis 
spectrophotometer.  The peak absorbance could later be used to ensure the proteins had not 
denatured and determine approximate batch sizes.  This is all possible because of the Beer-
Lambert Law [10] which relates concentration as directly proportional to absorption. 
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 A 2 mL sample of each solution was scanned separately on the spectrophotometer with 
wavelengths from 190 nm – 400 nm.  Then a 50:50 mixture (1 mL of each) was run through a 
similar scan and the results from all three scans were compared (Figure 2). 
 
11.4 Avidin-Glucose Oxidase Nanotube Fabrication 
 The layer-by-layer method was employed to fabricate the avidin nanotubes.  This method 
utilizes the protein’s electrostatic charges.  By alternately filtering positively and negatively 
charged proteins through a 200 nm anodized aluminum oxide (AAO) template one protein layer 
is formed.  
First the filtration is set up as seen in Figure 3, where it can drain into a flask which is 
connected to a vacuum pump.  The membranes used were commercially available filters made 
by Whatman. 
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Figure 4: SEM Images of AAO Template 
 Then 200 µL of PBS is filtered through to remove any loose material from the inner 
pores, followed by 200 µL avidin solution, and then 200 µL GOx.  This creates one layer on the 
200 nm pore walls of the AAO template (Figure 5).  By repeating this process multiple times the 
thickness of the nanotube walls can be controlled.   
 The 50 nm polycarbonate membrane below the 200 nm AAO template serves to slow the 
flow of solution through the 200 nm AAO template pores.  This allows more time for binding 
than would be possible if the solution drained straight through the AAO template pores. 
 Upon reaching the desired number of protein layers 1 mL of PBS was flushed through the 
filtration setup to remove any loose proteins.   
11.5 Avidin- Glucose Oxidase Nanotube Liberation 
 Frittered Glass 
50 nm Polycarbonate 
200 nm AAO 
Figure 3: Vacuum Filter 
Template Setup 
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 The AAO template was then dissolved in 10 mL of 0.1M Sodium Hydroxide (NaOH).  
Once completely dissolved, the NaOH was vacuum-filtered through a similar setup as Figure 3, 
but without the 200 nm AAO template.  This collected the 200 nm outer diameter (OD) tubes, 
while allowing the NaOH to pass through the 50 nm polycarbonate filter.  Filtration often took 
longer than 24 hours. 
 The polycarbonate filter was then placed in 2 mL of DI water to re-suspend the nanotubes 
into solution.  Upon collecting the nanotubes the solution was then scanned by UV-vis to verify 
the presence of the nanotubes.  Previous tests had determined peak absorbance of avidin and 
GOx to be around 290 nm.  Thus, the scan should show a peak around this wavelength as shown 
in Figure 2. 
 
Figure 5: Av-GOx NTS Fabrication Schematic 
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11.5.1 Determining the Best Solvent 
After problems arose with NaOH two other solvents were tried at the following 
concentrations: 
Solvent 
(10 mL each) 
0.1M NaOH 
0.1M HCl 
0.5M H3PO4 
Table 1: Solvent Concentration 
10 mL of each solvent was pipetted into separate petri dishes and one AAO template was 
submerged in each.  Each dish was marked as to its contents and then observed over 48 hours as 
often as possible.  It was noted whether the template completely dissolved and whether or not 
there was a precipitate.   
11.6 Characterization 
 A variety of techniques were used to characterize the nanotubes.   When the nanotubes 
were initially being liberated from the templates and suspended in solution, UV-vis spectroscopy 
was used to measure the absorbance of the solution.  Absorbance could theoretically be 
translated to nanotube density in solution if compared to previously made Absorbance vs. 
Concentration graphs of the proteins (see Figure 8 & Figure 9).   Another technique used to 
characterize the nanotubes was glucose activity assays, which is another type of absorbance 
measurement.  Finally, scanning electron microscopy (SEM) and transmission electron 
microscopy (TEM) were used to measure and photograph the nanotubes.  It should be noted that 
most characterization was done while the nanotubes were still template bound as the effect of the 
NaOH on the nanotube structure was in question. 
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11.6.1 Glucose Activity Assay 
The glucose activity assay sought to confirm that the GOx molecules had not been 
significantly altered during the nanotube fabrication.  Glucose oxidase is an enzyme which 
catalyzes the decomposition of glucose to gluconic acid [5].  By measuring the change of 
absorbance with UV-vis spectroscopy over time the reaction can verify the enzymatic activity of 
GOx is retaining its function.   
To perform this assay the following solutions were made: 
Reagent Molar Concentration 
Phenol 13 mM 
4-aminoantipyrine 0.7 mM 
Peroxidase 10 units 
Glucose 0.1 M 
Table 2: Glucose oxidase activity assay reagants 
One part of each of the above solutions was then mixed in a petri dish.  The template 
bound tubes were then submerged in the dish and incubated at 37ºC for 5 minutes.  Then 2 mL of 
the solution was pipetted into a cuvette and absorbance was measured at 515 nm over 5 minutes 
with measurements being recorded every 10 seconds.  The data was then plotted in Microsoft 
Excel for a visual representation of the change in absorbance over time. 
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12 Results  
12.1 Best Chemical for Dissolving Templates 
 
Solvent 
(10 mL Each) 
Time to Completely Dissolve 
(Hours) 
Precipitate After Dissolving 
(Yes/ No) 
0.1M NaOH < 3 
(48+ with NTS crosslinked w/ GA) 
No 
(Yes with NTS crosslinked w/ GA) 
0.1M HCl 48+ No 
0.5M H3PO4 24+ No 
Table 3: Chemical results for dissolving templates 
 Given the results from these tests, 0.1M NaOH was chosen as the best chemical for 
dissolving the AAO templates.  The only times it failed to completely dissolve the template was 
in the presence of avidin NTS crosslinked with GA.  Additionally, other instances outside of this 
test had shown a precipitate to form when using 0.1M NaOH.   
12.2 Avidin LbL Nanotubes Crosslinked with GA 
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                  Figure 6:  5 Layer Avidin NTS Absorbance Scan 
 The peak absorbance at 290 nm does indicate the presence of avidin in this early attempt 
at avidin nanotubes.  The peaks preceding the 290 nm peak are in stark contrast to the nearly flat 
area before the 290 nm peak in Figure 2.  The peaks could be the result of loose proteins rather 
than avidin nanotubes.  SEM images of the templates indicate no avidin nanotubes. 
12.3 Avidin-Glucose Oxidase Nanotubes 
Figure 7 shows a TEM image of an avidin-glucose oxidase nanotube.  The template used 
for this particular nanotube was soaked in binding agents (phosphonic acid followed by 
glutaralydehyde) to protect against the NaOH used to dissolve the AAO template. 
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Figure 7: TEM image of avidin-glucose oxidase nanotube (scale bar represents 100 nm) 
12.3.1 Concentration Test 
The effects of protein concentration in the stock solution on nanotube formation were 
determined by UV-vis.  Each solution was scanned before use between wavelengths of 250nm-
500nm.  The graphs generated from these scans are seen below.  A scan was also performed on a 
50% Avidin – 50% Glucose solution to represent the ratio of proteins in the nanotubes.   
The peaks around 280 nm clearly indicate the presence of the proteins in solution.  Since 
the Beer-Lambert Law states that absorption is directly proportional to concentration the higher 
peaks should correspond to higher concentrations.  However, the graphs below clearly indicate a 
different pattern, which appears to be almost random.  The 0.5 mg/mL solutions should have 
been between the other two curves but appear as the lowest in the scans of the individual protein 
solutions and then the highest in the 50-50 Avidin Glucose mix.  This is contrary to any logic 
provided by the Beer-Lambert law.  These scans should be repeated with disposable cuvettes to 
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check for repeatability of the results.  It is possible that even though the cuvettes were thoroughly 
cleaned between each use there may have been some residue that affected the absorbance.   
 
Figure 8: Avidin Stock Solution Scan of Three Concentrations 
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Figure 9: Glucose Oxidase Solution Scan of Three Concentrations 
 
Figure 10: 50% Avidin - 50% Glucose Oxidase Scan of Three Concentrations 
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 The absorbance rates (A/min) shown in Figure 11 are all similar, with the curve of 1 
mg/ml having a slightly larger slope than the other two, thus the fastest absorbance rate.  Even 
though its absorbance is the lowest, having the fastest absorbance rate means that the glucose 
oxidase catalyzed the oxidation of glucose the fastest.  Therefore, the proteins in these 1 mg/mL 
maintained the best functionality and/or had the greatest number of exposed proteins.   
 
Figure 11: Nanotube Concentration Study (Note: Each curve represents the averages of rates from three templates filled 
with nanotubes from solutions of the same concentration.) 
12.3.2 Solution Volume Test 
As can be seen in Figure 12 there is an increase in absorbance from 100 µL to 200 µL.  
This shows that at 100 µL the protein did not have enough time to fully bind to the inner pore 
surface, resulting in incomplete nanotubes.  However, between 200 µL and 300 µL there is a 
plateau representing protein saturation in the nanochannels occurring at 200 µL.   
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Figure 12: Solution Volume vs. Protein Activity of template bound Av-GOx NTS 
12.3.3 Dry Storage Time Test 
Protein activity rates show a clear decrease in the nanotubes when being stored dry.  
Figure 13 shows that after eleven days of being stored dry the protein nanotubes are at less than 
half of the activity they were directly after initial fabrication. 
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Figure 13: Av-GOx NTS activity as a function of storage time 
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13 Analysis and Discussion 
13.1 Template Dissolving 
The tests performed here indicated that NaOH was the best chemical for dissolving the 
AAO templates in a reasonable amount of time.  However, the NaOH was too strong for the 
proteins and was most likely destroying the electrostatic bonds holding the protein layers 
together.   
One approach to this problem would be to investigate new template materials.  Finding 
the correct combination of template and solvent would be crucial in liberating the nanotubes. 
Another approach would be soaking the templates in a crosslinking agent such as GA 
after protein deposition.  This should support the weak electrostatic bonds in holding up to strong 
solvents. 
13.2 Avidin Nanotubes 
The early attempts at manipulating the charge of one protein (avidin) alone to create 
electrostatic bonds showed unfavorable results.  At this point it is suggested that a more 
successful approach is manipulating the charge of two proteins with opposite isoelectric points in 
a solution of similar pH. 
13.3 Avidin-Glucose Oxidase Process Variables 
13.3.1 Solution Concentration 
Absorbances measured in characterization of variable solution concentration exceeded 
the expected range.  As a result, the data collected here was seen as invalid.  The most likely 
cause of the flawed data was an undetermined source within the glucose oxidase activity assay 
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chemicals.  There is a wide array of methods for calculating glucose oxidase activity.  It is 
suggested that an alternative activity assay be used in determining the effect of solution 
concentration on the nanotube formation. 
13.3.2 Solution Volume 
It was important to determine the ideal volume of protein solution to filter through the 
templates each time a layer was deposited.  Filtering too much solution would waste time and 
valuable protein; whereas, not filtering enough solution would leave the nanotubes incomplete.  
As seen in Figure 12, protein activity increases from 100 µL to 200 µL.  This shows that the 
nanotubes were incomplete when 100 µL was being used.  However, from 200 µL to 300 µL 
there is a plateau showing that the nanopores were saturated with protein at 200 µL.  Thus 200 
µL was seen as the ideal volume at 1 mg/mL concentration. 
13.3.3 Storage Time 
If protein nanotubes are to enter commercial applications their shelf-life needs to be 
understood.  When storing the nanotubes dry within a template, our tests showed that protein 
activity severely decreases as a function of time (Figure 13).  For any commercial application 
such a short shelf-life is unacceptable.  Thus better storage techniques need to be investigated.  
Temperature and medium (liquid, gas, etc.) both need to be considered for maintaining the 
activity of the protein NTS. 
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14 Conclusions 
In conclusion, fabrication of protein nanotubes is possible through a relatively simple 
procedure.  Electrostatic charges are significant enough to initially bind protein layers together; 
however, they may not stand up to the rigors of strong chemicals used to dissolve AAO 
templates.  This problem may be effectively circumvented by the use of binding agents such as 
GA.   
It is necessary to note the effect of process variables on the final product as uniformity 
will be necessary for any commercial applications.  Both solution volume and storage time had 
notable consequence on the final product. 
Finally, the methodologies developed here afford the user with great control.  This 
methodology can be applied to nearly any two proteins with significantly different isoelectric 
points.  Also, dimensions can be controlled easily by choice of template. 
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15 Recommendations 
It is recommended that future studies on template assisted layer-by-layer fabrication of 
protein nanotubes investigate the following: 
1. The effect of chemicals used to liberate the nanotubes 
 It is likely that the chemicals used are too severe for protein nanotubes 
held together solely by electrostatic charge.  New combinations of 
template, chemicals, and binding agents should be investigated in a 
manner that keeps the overall procedure simple, quick and inexpensive. 
2. The scalability of this approach 
 One of the major advantages to layer-by-layer methodology is its relative 
speed and simplicity.  It should be investigated how these qualities could 
aid in the large scale production of protein nanotubes if this technology 
were to be taken on for major commercial applications. 
3. Characterization of nanotube properties 
 The net charge, solubility, cell internalization capability, and drug 
attachment potential of these specific nanotubes should all be investigated.  
Another major benefit of layer-by-layer approaches being the control that 
the user has over these properties (specifically dimensions).  Therefore, 
once the properties of these specific nanotubes are known they can be 
tweaked to better suit their potential applications. 
 Developing a controlled cleaving process to regulate nanotube length was 
one of the original goals that did not come to fruition in this study.  Future 
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studies should investigate if this is necessary and how it could be 
performed (mechanical shearing, etc.). 
  
42 
 
16 Glossary 
Avidin (n.): A protein, found in the white of egg that combines with and prevents the action of biotin, 
thus injuring the animal that consumes it in excess by producing biotin deficiency.              
(http://dictionary.com ) 
Glucose Oxidase (n.): An enzyme which converts glucose into gluconic acid and hydrogen peroxide 
(H2O2). It is used to help diagnose diabetes. (http://cancerweb.ncl.ac.uk/cgi-bin/omd?glucose+oxidase )  
Glutaraldehyde (n.): A compound C5H8O2 that contains two aldehyde groups and is used as a 
disinfectant and in fixing biological tissues. (http://dictionary.com ) 
Isoelectric point (n.):  The pH at which a protein would have a net neutral charge. 
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